| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/19/2003 | EP1165559B1 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics |
| 02/19/2003 | EP1133491B1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 02/19/2003 | EP1056749B1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS |
| 02/19/2003 | CN1398300A Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative |
| 02/19/2003 | CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 02/19/2003 | CN1398247A Colchinol derivatives as vascular damaging agents |
| 02/19/2003 | CN1397554A Novel N-benzyl diethylenediamine compound, its prepn. process and medicinal compsns. contg. them |
| 02/19/2003 | CN1397550A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 02/19/2003 | CN1397547A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 02/19/2003 | CN1397541A Trijuganone and its derivative, and its preparing process and application |
| 02/19/2003 | CN1397345A Ouabain conjugated peptide or protein and its application in treating hypertension |
| 02/19/2003 | CN1397340A Medicine for treating cerebral infarction |
| 02/19/2003 | CN1397339A Antihypertensive medical band |
| 02/19/2003 | CN1397338A Preparing process and application of fresh ginger extract |
| 02/19/2003 | CN1397327A Liquid medicine for treating dermatopathy |
| 02/19/2003 | CN1397324A Compound chinese medicine for treating cerebrovascular disease |
| 02/19/2003 | CN1397289A Medicine for preventing and treating cerebral thrombosis and its preparing process |
| 02/19/2003 | CN1397288A 'Fuling Yangxin Anzang' pill for nourishing heart and viscera |
| 02/19/2003 | CN1397278A Process for preparing slow-releasing indapamide tablet |
| 02/19/2003 | CN1397276A Preparing process and medical application of SLA-A contained in red sage root and its composition |
| 02/19/2003 | CN1397273A Mechanical skeleton type pile suppository |
| 02/19/2003 | CN1101816C Substituted purine derivatives, processes for their prepn. their use, and compsns. comprising them |
| 02/19/2003 | CN1101815C 3-aminochromanylsulfonyl (thio) ureas, processes for their prepn. their use, and pharmaceutical prepn. comprising them |
| 02/19/2003 | CN1101692C Method for preparing Chinese medicine for curing apoplexy and hemiparalysis |
| 02/19/2003 | CN1101680C Use of thienotriazolodia zepine to increase apolipoprotein A-I levels |
| 02/19/2003 | CN1101678C Benzopyran derivative and use of said benzopyran derivative for treating heart disease |
| 02/19/2003 | CA2420065A1 Methods for indentifying specifically cleavable peptides and use of such peptide sequences |
| 02/18/2003 | WO2002018356A1 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 02/18/2003 | WO2002016329A1 Novel phenylalanine derivatives |
| 02/18/2003 | US6521760 Process for the preparation of zofenopril calcium salt |
| 02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |
| 02/18/2003 | US6521663 Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors |
| 02/18/2003 | US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them |
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521643 Pyridine compounds and their pharmaceutical use |
| 02/18/2003 | US6521640 Method for interviewing neuronal death using sulfasalazine |
| 02/18/2003 | US6521631 Heterocyclic sulfonamides |
| 02/18/2003 | US6521450 Cells expressing a modified regulator of complement activation |
| 02/18/2003 | US6521437 Human sphingosine lyase polypeptides |
| 02/18/2003 | US6521414 Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1 |
| 02/18/2003 | US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders |
| 02/18/2003 | US6521262 Solid instant-release forms of administration and process for producing the same |
| 02/18/2003 | US6521248 Cavitation; reduced pressure; oxygenated water |
| 02/18/2003 | US6521226 Administering Paraoxonase-1 (PON-1), an expressed protein that has hydrolase activity for organophosphates, and antioxidation activity for low-density lipoprotein (LDL) |
| 02/18/2003 | US6521212 Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation |
| 02/18/2003 | CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 02/18/2003 | CA2419838A1 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 02/18/2003 | CA2079289C Cardioprotective tocopherol analogs |
| 02/18/2003 | CA2064331C Vascular endothelial cell growth factor c subunit |
| 02/15/2003 | CA2397371A1 Pharmaceutical combinations for the treatment of neurodegenerative diseases |
| 02/15/2003 | CA2392305A1 Adrenic acid receptor and uses thereof |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003012105A2 Vegf isoform |
| 02/13/2003 | WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof |
| 02/13/2003 | WO2003012093A2 Regulator of calcineurin |
| 02/13/2003 | WO2003012030A2 Isoform-selective inhibitors and activators of pde3 cyclic |
| 02/13/2003 | WO2003011906A2 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest |
| 02/13/2003 | WO2003011899A2 Antigenic polypeptides |
| 02/13/2003 | WO2003011896A1 Peptides having antiangiogenic activity |
| 02/13/2003 | WO2003011892A2 Glp-1 exendin-4 peptide analogs and uses thereof |
| 02/13/2003 | WO2003011887A2 Antisense modulation of apolipoprotein b expression |
| 02/13/2003 | WO2003011880A1 Glucopyrano syloxybenzyl benzene derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 02/13/2003 | WO2003011872A1 Platelet adp receptor inhibitors |
| 02/13/2003 | WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | WO2003011864A1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS |
| 02/13/2003 | WO2003011858A1 Substituted isoindoles and e use thereof |
| 02/13/2003 | WO2003011855A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | WO2003011839A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011834A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 02/13/2003 | WO2003011833A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
| 02/13/2003 | WO2003011830A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 02/13/2003 | WO2003011827A1 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives |
| 02/13/2003 | WO2003011823A2 Crfr1 selective ligands |
| 02/13/2003 | WO2003011819A1 Butyric acid derivatives |
| 02/13/2003 | WO2003011814A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 02/13/2003 | WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME |
| 02/13/2003 | WO2003011810A1 Method for the nitration of phenolic compounds |
| 02/13/2003 | WO2003011808A1 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 02/13/2003 | WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | WO2003011384A1 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 02/13/2003 | WO2003011345A1 Lipid constructs as therapeutic and imaging agents |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011315A1 Composition for inhibiting tyrosine kinase activity of src proteins |
| 02/13/2003 | WO2003011309A2 Pharmaceutical composition for treating hypercholesterolaemia |
| 02/13/2003 | WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| 02/13/2003 | WO2003011302A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | WO2003011301A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 02/13/2003 | WO2003011300A1 As-needed administration of orally active androgenic agents to enhance female sexual desire and responsiveness |
| 02/13/2003 | WO2003011296A1 Pharmaceutical preparations containing aminobenzene- sulfonic acid derivatives as the active ingredient |
| 02/13/2003 | WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 02/13/2003 | WO2003011283A1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 02/13/2003 | WO2003011279A1 (-)-olivil as antioxidant |
| 02/13/2003 | WO2003011276A1 Nf?b inhibitor |
| 02/13/2003 | WO2003011268A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |